MBX Biosciences, Inc. (MBX)
53.31
-1.23
(-2.26%)
USD |
NASDAQ |
Oct 08, 16:00
53.31
0.00 (0.00%)
After-Hours: 20:00
MBX Biosciences EPS Diluted (Quarterly) : -0.7777 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7777 |
| March 31, 2026 | -0.5049 |
| December 31, 2025 | -0.4917 |
| September 30, 2025 | -0.6321 |
| June 30, 2025 | -0.5804 |
| March 31, 2025 | -0.7147 |
| December 31, 2024 | -0.4664 |
| Date | Value |
|---|---|
| September 30, 2024 | -0.5436 |
| June 30, 2024 | -0.4751 |
| March 31, 2024 | -0.3696 |
| December 31, 2023 | -0.265 |
| September 30, 2023 | -0.3045 |
| June 30, 2023 | -0.228 |
| March 31, 2023 | -0.1782 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amylyx Pharmaceuticals, Inc. | -0.3905 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.10M |
| Total Expenses (Quarterly) | 37.10M |
| Enterprise Value | 2.200B |
| Earnings Yield | -4.51% |
| Normalized Earnings Yield | -4.514 |